Skip to main content

Court of Appeals Rejects Overturn of $12.8 Million Verdict

Court of Appeals Rejects Overturn of $12.8 Million Verdict

Court of Appeals Rejects Overturn of  $12.8 Million Verdict

Introduction

A state appeals court panel rejected the proposal to overturn a $12.8 million verdict against Johnson & Johnson's subsidiary Ethicon Inc. over their surgical mesh implant lawsuit filed by a plaintiff. Judge Victor P. Stabile confirmed Ethicon is liable to pay the damages to the woman for her post-surgery complications.

In 2009, the plaintiff underwent surgery to implant Ethicon Prolift Kit mesh in her body. The defective design of the mesh left her with serious problems including chronic vaginal pain during sexual intercourse and vaginal mesh erosion, requiring three corrective surgeries. She filed a product liability lawsuit in 2013 against Ethicon for failing to warn the doctors about the potential risks of the mesh. Judge Stabile rejected the manufacturer's claim that Pennsylvania courts don't have jurisdiction in the case, and that the evidence does not support the damage verdict.

Several women across the U.S. who implanted transvaginal mesh to treat pelvic organ prolapse (POP) and stress urinary incontinence (SUI) claim about the inadequate warning from the mesh makers. More than 100,000 transvaginal mesh lawsuits are federally-filed against various manufacturers. Ethicon Hernia Mesh lawsuits are consolidated as a part of multidistrict litigation (MDL No.2782;  In Re: Ethicon Physiomesh Flexible Composite Hernia Mesh Products Liability Litigation) before U.S. District Judge Richard Story in the Northern District of Georgia.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

NC to Get $150M to Boost Opioid Treatment, Recovery

Categories: Opioids

North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!